DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 8 of 8 descriptions
Filter by
Reset
|
No.
Drug (Description in trials)
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
Disease ID
1
89ZR-BEVACIZUMAB
(
Avastin
(TN))
[2]
Bevacizumab
Bevacizumab
(
Avastin
),
Bevacizumab zirconium Zr-89
[1]
Bevacizumab
Bevacizumab
(
Avastin
(TN))
💬
1. 89ZR-BEVACIZUMAB
×
Name
Other Names
Bevacizumab
Bevacizumab (USAN)
Bevacizumab (genetical recombination) (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)
Bevacizumab-awwb
Bevacizumab-bvzr
Avastin (TN)
Mvasi (TN)
ALYMSYS
ZIRABEV
[1]
VEGFA
VEGFA
💬
1. 89ZR-BEVACIZUMAB
×
Name
Full Name
VEGFA
vascular endothelial growth factor A
[24]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
,
Chemical carcinogenesis - reactive oxygen species
,
Chemical carcinogenesis - receptor activation
,
EGFR tyrosine kinase inhibitor resistance
,
Fluid shear stress and atherosclerosis
,
Focal adhesion
,
HIF-1 signaling pathway
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Kaposi sarcoma-associated herpesvirus infection
,
MAPK signaling pathway
,
MicroRNAs in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Proteoglycans in cancer
,
Rap1 signaling pathway
,
Ras signaling pathway
,
Relaxin signaling pathway
,
Renal cell carcinoma
,
Rheumatoid arthritis
,
VEGF signaling pathway
💬
[24]
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
...
[1]
34
34
💬
1. 89ZR-BEVACIZUMAB
×
Disease ID
Name
34
Neurofibromatosis
2
AVASTIN
[1]
Bevacizumab
Bevacizumab
(
Avastin
)
[1]
Bevacizumab
Bevacizumab
(
Avastin
(TN))
💬
2.
AVASTIN
×
Name
Other Names
Bevacizumab
Bevacizumab (USAN)
Bevacizumab (genetical recombination) (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)
Bevacizumab-awwb
Bevacizumab-bvzr
Avastin (TN)
Mvasi (TN)
ALYMSYS
ZIRABEV
[1]
VEGFA
VEGFA
💬
2.
AVASTIN
×
Name
Full Name
VEGFA
vascular endothelial growth factor A
[24]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
,
Chemical carcinogenesis - reactive oxygen species
,
Chemical carcinogenesis - receptor activation
,
EGFR tyrosine kinase inhibitor resistance
,
Fluid shear stress and atherosclerosis
,
Focal adhesion
,
HIF-1 signaling pathway
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Kaposi sarcoma-associated herpesvirus infection
,
MAPK signaling pathway
,
MicroRNAs in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Proteoglycans in cancer
,
Rap1 signaling pathway
,
Ras signaling pathway
,
Relaxin signaling pathway
,
Renal cell carcinoma
,
Rheumatoid arthritis
,
VEGF signaling pathway
💬
[24]
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
...
[1]
227
227
💬
2.
AVASTIN
×
Disease ID
Name
227
Osler disease
3
AVASTIN
25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung
[1]
Bevacizumab
Bevacizumab
(
Avastin
)
[1]
Bevacizumab
Bevacizumab
(
Avastin
(TN))
💬
3.
AVASTIN
25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung
×
Name
Other Names
Bevacizumab
Bevacizumab (USAN)
Bevacizumab (genetical recombination) (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)
Bevacizumab-awwb
Bevacizumab-bvzr
Avastin (TN)
Mvasi (TN)
ALYMSYS
ZIRABEV
[1]
VEGFA
VEGFA
💬
3.
AVASTIN
25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung
×
Name
Full Name
VEGFA
vascular endothelial growth factor A
[24]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
,
Chemical carcinogenesis - reactive oxygen species
,
Chemical carcinogenesis - receptor activation
,
EGFR tyrosine kinase inhibitor resistance
,
Fluid shear stress and atherosclerosis
,
Focal adhesion
,
HIF-1 signaling pathway
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Kaposi sarcoma-associated herpesvirus infection
,
MAPK signaling pathway
,
MicroRNAs in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Proteoglycans in cancer
,
Rap1 signaling pathway
,
Ras signaling pathway
,
Relaxin signaling pathway
,
Renal cell carcinoma
,
Rheumatoid arthritis
,
VEGF signaling pathway
💬
[24]
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
...
[1]
227
227
💬
3.
AVASTIN
25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung
×
Disease ID
Name
227
Osler disease
4
Bevacizumab
(
Avastin
(TN))
[1]
Bevacizumab
Bevacizumab
(
Avastin
)
[1]
Bevacizumab
Bevacizumab
(
Avastin
(TN))
💬
4. Bevacizumab
×
Name
Other Names
Bevacizumab
Bevacizumab (USAN)
Bevacizumab (genetical recombination) (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)
Bevacizumab-awwb
Bevacizumab-bvzr
Avastin (TN)
Mvasi (TN)
ALYMSYS
ZIRABEV
[1]
VEGFA
VEGFA
💬
4. Bevacizumab
×
Name
Full Name
VEGFA
vascular endothelial growth factor A
[24]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
,
Chemical carcinogenesis - reactive oxygen species
,
Chemical carcinogenesis - receptor activation
,
EGFR tyrosine kinase inhibitor resistance
,
Fluid shear stress and atherosclerosis
,
Focal adhesion
,
HIF-1 signaling pathway
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Kaposi sarcoma-associated herpesvirus infection
,
MAPK signaling pathway
,
MicroRNAs in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Proteoglycans in cancer
,
Rap1 signaling pathway
,
Ras signaling pathway
,
Relaxin signaling pathway
,
Renal cell carcinoma
,
Rheumatoid arthritis
,
VEGF signaling pathway
💬
[24]
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
...
[6]
13
13
,
34
,
85
,
87
,
227
,
280
💬
4. Bevacizumab
×
Disease ID
Name
13
Multiple sclerosis/Neuromyelitis optica
34
Neurofibromatosis
85
Idiopathic interstitial pneumonia
87
Pulmonary veno-occlusive disease
227
Osler disease
280
Huge arteriovenous malformation with cervicofacial or limb lesion
5
Bevacizumab (
Avastin
) and Imatinib Mesylate (Gleevec)
[2]
Bevacizumab
Bevacizumab
(
Avastin
),
Imatinib
[2]
Bevacizumab
Bevacizumab
(
Avastin
(TN))
,
Imatinib
💬
5. Bevacizumab (
Avastin
) and Imatinib Mesylate (Gleevec)
×
Name
Other Names
Bevacizumab
Bevacizumab (USAN)
Bevacizumab (genetical recombination) (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)
Bevacizumab-awwb
Bevacizumab-bvzr
Avastin (TN)
Mvasi (TN)
ALYMSYS
ZIRABEV
Imatinib
Imatinib (INN)
Glamox (TN)
[4]
ABL1
ABL1
,
KIT
,
PDGFRA
,
VEGFA
💬
5. Bevacizumab (
Avastin
) and Imatinib Mesylate (Gleevec)
×
Name
Full Name
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
KIT
KIT proto-oncogene, receptor tyrosine kinase
PDGFRA
platelet derived growth factor receptor alpha
VEGFA
vascular endothelial growth factor A
[45]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Acute myeloid leukemia
,
Axon guidance
,
Bladder cancer
,
Breast cancer
,
Calcium signaling pathway
,
Cell cycle
,
Central carbon metabolism in cancer
,
Chemical carcinogenesis - reactive oxygen species
,
Chemical carcinogenesis - receptor activation
,
Choline metabolism in cancer
,
Chronic myeloid leukemia
,
EGFR tyrosine kinase inhibitor resistance
,
Endocytosis
,
ErbB signaling pathway
,
Fluid shear stress and atherosclerosis
,
Focal adhesion
,
Gap junction
,
Glioma
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
JAK-STAT signaling pathway
,
Kaposi sarcoma-associated herpesvirus infection
,
MAPK signaling pathway
,
Melanogenesis
,
Melanoma
,
MicroRNAs in cancer
,
Neurotrophin signaling pathway
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathogenic Escherichia coli infection
,
Pathways in cancer
,
Phospholipase D signaling pathway
,
Prostate cancer
,
Proteoglycans in cancer
,
Rap1 signaling pathway
,
Ras signaling pathway
,
Regulation of actin cytoskeleton
,
Relaxin signaling pathway
,
Renal cell carcinoma
,
Rheumatoid arthritis
,
VEGF signaling pathway
,
Viral myocarditis
💬
[45]
AGE-RAGE signaling pathway in diabetic complications
,
Acute myeloid leukemia
,
Axon guidance
,
Bl
...
[1]
87
87
💬
5. Bevacizumab (
Avastin
) and Imatinib Mesylate (Gleevec)
×
Disease ID
Name
87
Pulmonary veno-occlusive disease
6
Bevacizumab (Genitical Recombination)
(
Avastin
(TN))
[1]
Bevacizumab
Bevacizumab
(
Avastin
)
[1]
Bevacizumab
Bevacizumab
(
Avastin
(TN))
💬
6. Bevacizumab (Genitical Recombination)
×
Name
Other Names
Bevacizumab
Bevacizumab (USAN)
Bevacizumab (genetical recombination) (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)
Bevacizumab-awwb
Bevacizumab-bvzr
Avastin (TN)
Mvasi (TN)
ALYMSYS
ZIRABEV
[1]
VEGFA
VEGFA
💬
6. Bevacizumab (Genitical Recombination)
×
Name
Full Name
VEGFA
vascular endothelial growth factor A
[24]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
,
Chemical carcinogenesis - reactive oxygen species
,
Chemical carcinogenesis - receptor activation
,
EGFR tyrosine kinase inhibitor resistance
,
Fluid shear stress and atherosclerosis
,
Focal adhesion
,
HIF-1 signaling pathway
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Kaposi sarcoma-associated herpesvirus infection
,
MAPK signaling pathway
,
MicroRNAs in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Proteoglycans in cancer
,
Rap1 signaling pathway
,
Ras signaling pathway
,
Relaxin signaling pathway
,
Renal cell carcinoma
,
Rheumatoid arthritis
,
VEGF signaling pathway
💬
[24]
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
...
[1]
34
34
💬
6. Bevacizumab (Genitical Recombination)
×
Disease ID
Name
34
Neurofibromatosis
7
BEVACIZUMAB ZIRCONIUM ZR-89
(
Avastin
(TN))
[2]
Bevacizumab
Bevacizumab
(
Avastin
),
Bevacizumab zirconium Zr-89
[1]
Bevacizumab
Bevacizumab
(
Avastin
(TN))
💬
7. BEVACIZUMAB ZIRCONIUM ZR-89
×
Name
Other Names
Bevacizumab
Bevacizumab (USAN)
Bevacizumab (genetical recombination) (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)
Bevacizumab-awwb
Bevacizumab-bvzr
Avastin (TN)
Mvasi (TN)
ALYMSYS
ZIRABEV
[1]
VEGFA
VEGFA
💬
7. BEVACIZUMAB ZIRCONIUM ZR-89
×
Name
Full Name
VEGFA
vascular endothelial growth factor A
[24]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
,
Chemical carcinogenesis - reactive oxygen species
,
Chemical carcinogenesis - receptor activation
,
EGFR tyrosine kinase inhibitor resistance
,
Fluid shear stress and atherosclerosis
,
Focal adhesion
,
HIF-1 signaling pathway
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Kaposi sarcoma-associated herpesvirus infection
,
MAPK signaling pathway
,
MicroRNAs in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Proteoglycans in cancer
,
Rap1 signaling pathway
,
Ras signaling pathway
,
Relaxin signaling pathway
,
Renal cell carcinoma
,
Rheumatoid arthritis
,
VEGF signaling pathway
💬
[24]
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
...
[1]
34
34
💬
7. BEVACIZUMAB ZIRCONIUM ZR-89
×
Disease ID
Name
34
Neurofibromatosis
8
Submucosal Bevacizumab
(
Avastin
(TN))
[1]
Bevacizumab
Bevacizumab
(
Avastin
)
[1]
Bevacizumab
Bevacizumab
(
Avastin
(TN))
💬
8. Submucosal Bevacizumab
×
Name
Other Names
Bevacizumab
Bevacizumab (USAN)
Bevacizumab (genetical recombination) (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN)
Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN)
Bevacizumab-awwb
Bevacizumab-bvzr
Avastin (TN)
Mvasi (TN)
ALYMSYS
ZIRABEV
[1]
VEGFA
VEGFA
💬
8. Submucosal Bevacizumab
×
Name
Full Name
VEGFA
vascular endothelial growth factor A
[24]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
,
Chemical carcinogenesis - reactive oxygen species
,
Chemical carcinogenesis - receptor activation
,
EGFR tyrosine kinase inhibitor resistance
,
Fluid shear stress and atherosclerosis
,
Focal adhesion
,
HIF-1 signaling pathway
,
Human cytomegalovirus infection
,
Human papillomavirus infection
,
Kaposi sarcoma-associated herpesvirus infection
,
MAPK signaling pathway
,
MicroRNAs in cancer
,
PI3K-Akt signaling pathway
,
Pancreatic cancer
,
Pathways in cancer
,
Proteoglycans in cancer
,
Rap1 signaling pathway
,
Ras signaling pathway
,
Relaxin signaling pathway
,
Renal cell carcinoma
,
Rheumatoid arthritis
,
VEGF signaling pathway
💬
[24]
AGE-RAGE signaling pathway in diabetic complications
,
Bladder cancer
,
Calcium signaling pathway
...
[1]
227
227
💬
8. Submucosal Bevacizumab
×
Disease ID
Name
227
Osler disease